Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$919K Buy
3,497
+478
+16% +$128K 0.03% 254
2022
Q3
$680K Sell
3,019
-193
-6% -$46.8K 0.02% 285
2022
Q2
$782K Buy
3,212
+312
+11% +$76.5K 0.03% 257
2022
Q1
$701K Sell
2,900
-1,795
-38% -$412K 0.02% 285
2021
Q4
$1.06M Buy
4,695
+223
+5% +$47.1K 0.03% 218
2021
Q3
$951K Buy
4,472
+1,257
+39% +$289K 0.03% 217
2021
Q2
$784K Buy
3,215
+619
+24% +$152K 0.03% 246
2021
Q1
$646K Buy
2,596
+341
+15% +$81.4K 0.02% 252
2020
Q4
$518K Buy
2,255
+142
+7% +$32.7K 0.02% 250
2020
Q3
$537K Buy
2,113
+246
+13% +$60.9K 0.02% 221
2020
Q2
$440K Buy
1,867
+227
+14% +$51.8K 0.02% 237
2020
Q1
$332K Buy
1,640
+291
+22% +$63.6K 0.02% 242
2019
Q4
$309K Buy
1,349
+225
+20% +$49.6K 0.01% 267
2019
Q3
$218K Buy
+1,124
New +$216K 0.01% 304

Other funds holding AMGN

Cerity Partners OCIO's AMGN Position: Q4 2022 in Review

Cerity Partners OCIO increased its Amgen (AMGN) stake by 16% in Q4 2022, buying an estimated $128K and bringing the position to 3,497 shares worth $919K. The position accounts for 0.03% of the portfolio, ranked #254.

Cerity Partners OCIO first reported a position in AMGN in Q3 2019 and has held it in 14 quarters since. The position peaked at $1.06M in Q4 2021. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Cerity Partners OCIO held 3,497 shares of Amgen worth $919K as of Q4 2022.
  • Cerity Partners OCIO bought 478 Amgen shares in Q4 2022, an estimated $128K.
  • Amgen made up 0.03% of Cerity Partners OCIO's portfolio in Q4 2022, its #254 holding.
  • Cerity Partners OCIO first reported a position in Amgen in Q3 2019 and has held it in 14 quarters since.
  • Cerity Partners OCIO's Amgen position peaked at $1.06M in Q4 2021.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Cerity Partners OCIO's 13F filing for Q4 2022, filed 2 Feb 2023.